SURVEY OF GOOD PRESCRIBING PRACTICE OF KANOKAD AND FEIBA USED AS ANTAGONISTS OF DIRECT ORAL ANTICOAGULANTS (DOAs) AFTER IMPLEMENTATION OF A VALIDATED PROTOCOL
OHP-028
COST-EFFECTIVENESS OF TRIPLE THERAPY FOR HEPATITIS C COMPARED WITH DUAL THERAPY IN CLINICAL PRACTICE
OHP-027
LITERATURE ABOUT THE ROLE AND THE IMPACT OF PHARMACISTS: PERCEPTIONS OF PHARMACY STUDENTS
OHP-026
COSTS OF TRIPLE THERAPY AND THE HOSPITAL PHARMACIST'S ROLE
OHP-025
INVESTIGATIONS FOLLOWING INCREASING COMPLAINTS ABOUT INFUSION SETS FOR SAFE ADMINISTRATION OF CYTOSTATICS
OHP-024
PHARMACIST FOCUS GROUP ABOUT QUALITY OF MEDICINES AND RELATED ISSUES
OHP-023
IMPORTANCE OF PREVIOUS MICROBIAL CULTURES IN CARBAPENEMS USE
OHP-022
ADVANCES IN PHARMACY EDUCATION: EVALUATION OF A WARD-BASED CLINICAL TEACHING COURSE
OHP-021
IMPACT OF HOSPITAL PHARMACIST INTEGRATION OVER A GENERAL SURGERY SERVICE STAFF
OHP-020
PROSPECTIVE MONOCENTRIC STUDY: COMPLICATIONS RELATED TO PERIPHERALLY INSERTED CENTRAL CATHETERS (PICC)
OHP-019
BUDGET IMPACT OF FINGOLIMOD IN THE TREATMENT OF MULTIPLE SCLEROSIS
OHP-018
CHEMICAL DEGRADATION OF METHOXSALEN AFTER ACID AND ALKALINE HYDROLYSIS
OHP-017
ABILITY OF INFUSION DEVICES TO DELIVER THE EXPECTED VOLUME OF ANTINEOPLASTIC DRUG IN SOLUTION: AN IN VITRO ASSESSMENT
